Categorynews

Czech Republic’s Pharma & Healthcare Market 2019-2020 – ResearchAndMarkets.com

June 5, 2019 Off By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Czech
Republic’s Pharma & Healthcare Market 2019-2020” report has
been added to ResearchAndMarkets.com’s offering.

This report provides a complete and detailed analysis of the healthcare
and pharmaceutical sector for the Czech Republic . The researcher
presents in-depth business intelligence in a standard format across
countries and regions, providing a balanced mix between analysis and
data.

The gross value added (GVA) of the Czech pharmaceutical sector amounted
to CZK 19.4bn in 2017, increasing by a real 11.1% y/y. The sector
accounted for 0.4% of the GDP that year. The pharmaceutical sector
employed 9,855 workers in 2017, accounting for 0.2% of the total number
of employees.

Total healthcare expenditures amounted to CZK 358.8bn in 2017,
increasing by 5.3% y/y, according to OECD data. The increase was mainly
due to public healthcare expenditures, which rose by 4% y/y to CZK
293.3bn, having a share of 81.7% of total healthcare expenditures. Total
healthcare expenditures accounted for 7.1% of GDP in 2017. The human
health and social work activities employed 294,300 people in 2017,
accounting for 7.3% of the total employment in the country.

What this report allows you to do:

  • Understand the key elements at play in the healthcare and
    pharmaceutical sector in the Czech Republic
  • Access forecasts for growth in the sector
  • View key data on healthcare spending and health insurance in the Czech
    Republic
  • Crystallise the forces both driving and restraining this sector in the
    Czech Republic
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in
    the Czech Republic
  • Build a clear picture of trends and issues for sub-sectors (medical
    institutions, pharmaceuticals manufacturing and distribution channels)

Key Topics Covered

01 EXECUTIVE SUMMARY

  • Sector in Numbers
  • Sector Overview
  • Sector Snapshot
  • Sector Outlook
  • Sub-sector Outlook
  • Driving Forces
  • Restraining Forces

02 SECTOR IN FOCUS

  • Main Economic Indicators
  • Main Sector Indicators
  • Pharmaceutical Output and Gross Value
  • Added
  • Pharmaceutical Production
  • Sales
  • New Orders
  • Healthcare Expenditure
  • Global Positioning
  • Regional Positioning
  • External Trade
  • Foreign Direct Investments
  • Employment and Wages

03 COMPETITIVE LANDSCAPE

  • Timeline Czech Republic Pharma & Healthcare
  • Highlights
  • Top 20 Pharmaceutical Companies
  • Top M&A Deals
  • M&A Activity

04 COMPANIES IN FOCUS

  • Teva Pharmaceuticals CR s.r.o.
  • Zentiva k.s.
  • FARMAK a.s.
  • VUAB Pharma a.s.
  • Bioveta a.s.

05 REGULATORY ENVIRONMENT

  • Key Bodies
  • Health Insurance System
  • Government Policy VAT Rate
  • VAT Rate for Medicines in Europe 2017
  • Government Policy

06 HEALTHCARE SERVICES

  • Highlights
  • Main Events
  • Healthcare Expenditures
  • Healthcare Insurance Companies
  • Life Expectancy
  • Disease Trends and Risk Factors
  • Number of Hospitals
  • Cases of Hospitalisation
  • Focus Point – Number of Hospitals by Region
  • Number of Hospital Beds
  • Focus Point – Number of Beds in Hospitals
  • Healthcare Professionals
  • Medical Equipment

07 PRESCRIPTION DRUGS

  • Highlights
  • Prescription Drug Sales
  • Patented and Generic Drugs

08 OVER-THE-COUNTER DRUGS

  • Highlights
  • OTC Drug Sales

09 RETAIL CHANNELS

  • Retail

For more information about this report visit https://www.researchandmarkets.com/r/wzqpw5

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Healthcare
Services, Pharmaceuticals